Dyadic International Inc (DYAI)
1.65
-0.01
(-0.60%)
USD |
NASDAQ |
May 17, 16:00
1.66
+0.01
(+0.61%)
After-Hours: 20:00
Dyadic International Cash from Financing (Quarterly): 5.824M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.824M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.1415M |
| September 30, 2022 | 0.3597M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0423M |
| December 31, 2021 | 0.2445M |
| September 30, 2021 | -0.0006M |
| June 30, 2021 | 0.8703M |
| March 31, 2021 | 0.1158M |
| December 31, 2020 | 0.0247M |
| September 30, 2020 | 0.0001M |
| June 30, 2020 | 0.0557M |
| March 31, 2020 | 0.175M |
| December 31, 2019 | 0.2216M |
| September 30, 2019 | 0.1794M |
| June 30, 2019 | 0.1492M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -1.925M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.3748M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.5278M |
| September 30, 2017 | -0.0099M |
| June 30, 2017 | 0.0014M |
| March 31, 2017 | -5.686M |
| December 31, 2016 | -3.588M |
| September 30, 2016 | -3.691M |
| June 30, 2016 | -1.983M |
| March 31, 2016 | -3.858M |
| December 31, 2015 | -1.975M |
| September 30, 2015 | 0.005M |
| June 30, 2015 | 0.0208M |
| March 31, 2015 | 2.023M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.003M |
| September 30, 2013 | 0.0942M |
| June 30, 2013 | 0.0648M |
| March 31, 2013 | 0.0585M |
| September 30, 2012 | -0.0016M |
| June 30, 2012 | 0.0153M |
| March 31, 2012 | 0.0233M |
| December 31, 2006 | 12.80M |
| September 30, 2006 | 0.3444M |
| June 30, 2006 | 5.846M |
| March 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.0006M
Minimum
Sep 2021
5.824M
Maximum
Mar 2024
0.4202M
Average
0.0858M
Median
Cash from Financing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 0.147M |
| Perspective Therapeutics Inc | 166.33M |
| Protalix BioTherapeutics Inc | 0.00 |
| Electromed Inc | 0.056M |
| Armata Pharmaceuticals Inc | 34.93M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.113M |
| Cash from Investing (Quarterly) | -0.6549M |
| Free Cash Flow | -5.653M |
| Free Cash Flow Per Share (Quarterly) | -0.0386 |
| Free Cash Flow to Equity (Quarterly) | -6.940M |
| Free Cash Flow Yield | -11.89% |